Compare MTEK & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MTEK | ICCM |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 3.6M |
| IPO Year | 2021 | 2013 |
| Metric | MTEK | ICCM |
|---|---|---|
| Price | $0.28 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | ★ 231.3K | 110.0K |
| Earning Date | 09-02-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.11 |
| Revenue Next Year | N/A | $104.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.13 |
| 52 Week High | $2.82 | $9.54 |
| Indicator | MTEK | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 27.56 | 29.69 |
| Support Level | $0.21 | $0.65 |
| Resistance Level | $1.12 | $0.74 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 31.56 | 18.43 |
Maris Tech Ltd is a B2B provider of intelligent video transmission technology with AI acceleration for edge platforms, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures, and commercially sells miniature intelligent video and audio surveillance and communication systems with AI acceleration for the professional, civilian, and home security markets. Its products and solutions are sold as off-the-shelf, standalone, and ready-to-use products, or as customized components that meet customers' requirements and integrate into their systems and products. Its customers include companies operating in the drone, robotic, defense, HLS, intelligence gathering, autonomous vehicle, and space markets. It generates maximum revenue from Israel.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.